Short-term storage of the ischemically damaged human pancreas by the two-layer method prior to islet isolation.
A two-layer cold storage method (TLM) allows sufficient oxygen delivery to pancreata during preservation and resuscitates the viability of ischemically damaged pancreata in the canine pancreas transplant model. In this study, we applied a short-term preservation of the TLM to human pancreata after prolonged cold ischemia prior to islet isolation, and investigated the mechanisms of resuscitation of the ischemically damaged human pancreas by the TLM. Human pancreata were procured from cadaveric donors and preserved by the TLM for 3.2 +/- 0.5 h after 11.1 +/- 0.9 h of cold storage in UW (TLM group), or by cold UW alone for 11.0 +/- 0.3 h (UW group). Islet isolations of all pancreata were performed using the Edmonton protocol. Islet recovery and in vitro functional viability of isolated islets were significantly increased in the TLM group compared with the UW group. According to the criteria of the Edmonton protocol, 10/14 cases (71%) in the TLM group were transplanted to patients with type I diabetes mellitus compared with only 5/21 cases (24%) in the UW group. In the metabolic assessment of human pancreata, levels of energetic parameters (ATP, total adenylates, and energy charge) were significantly increased, and malondialdehyde (MDA) levels were significantly decreased after the TLM preservation. There was no observable change in the incidence or degree of mitochondrial injury after the TLM preservation. Additional short-term storage by the TLM resuscitates the ischemically damaged human pancreas by regenerating the energetic status and prevents further damage by oxidative stress, ultimately leading to improvements of islet recovery and in vitro function. Use of the TLM following prolonged storage in UW provides an excellent adjunctive protocol for treating human pancreata for the rigors of the islet isolation process.
Tsujimura
Toshiaki
T
Surgical-Medical Research Institute, Department of Surgery, University of Alberta, Edmonton, Alberta T6G2N8, Canada.
Kuroda
Yoshikazu
Y
Churchill
Thomas A
TA
Avila
Jose G
JG
Kin
Tatsuya
T
Shapiro
A M James
AM
Lakey
Jonathan R T
JR
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D000818:Animals; D002102:Cadaver; D002469:Cell Separation / Q000379:methods; D003080:Cold Temperature; D004285:Dogs; D006801:Humans; D007511:Ischemia; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000379:methods* / Q000473:pathology / Q000502:physiology; D008315:Malondialdehyde / Q000378:metabolism; D008875:Middle Aged; D008928:Mitochondria / Q000648:ultrastructure; D023421:Models, Animal; D010179:Pancreas / Q000473:pathology; D016035:Pancreas Transplantation / Q000379:methods / Q000502:physiology; D013997:Time Factors; D014019:Tissue Donors; D014021:Tissue Preservation / Q000379:methods*; D020858:Tissue and Organ Harvesting / Q000379:methods
D008315:Malondialdehyde; D000255:Adenosine Triphosphate